HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Dengue virus-1 NS5 genetic variant associated with a severe clinical infection: Possible reduction of the innate immune response by inhibition of interferon type 1 and the Janus kinase-signal transducer and activator of transcription signaling pathway.

Abstract
Dengue virus (DENV) is currently considered as one of the most important mosquito-borne viral pathogens affecting humans. Genetic variations in viruses are likely to be a condition for more effective evasion of the immune system and resulting in severe clinical consequences. The DENV‑1 NS5 gene was sequenced to establish whether during an epidemic burst there were genetic variations of the virus and whether any variant was associated (through a case‑control design) with severe clinical behavior. A total of 31 patients positive for DENV‑1 were enrolled. Among the nucleotide differences between the sequences, only two generated amino acid changes. The variants 124Met/166Ser (amino acid positions according to the report GenBank AJL35015.1), were associated with a severe clinical course of the disease. Via in silico tests, it was identified that the variations generate changes in the protein probably affecting the function of type‑1 interferon, either at the level of its receptor or by interfering with the Janus kinase‑signal transducer and activator of transcription signaling pathway.
AuthorsIván Delgado-Enciso, Uriel A López-Lemus, Jose A Valcarcel-Gamiño, Iram P Rodriguez-Sanchez, Salvador Valle-Reyes, Margarita L Martinez-Fierro, Valery Melnikov, José Guzmán-Esquivel, Felipe Vaca-Paniagua, Laura L Valdez-Velazquez, Luz M Baltazar-Rodriguez, Alejandro D Soriano-Hernandez, Brenda Paz-Michel, Francisco Espinoza-Gómez
JournalInternational journal of molecular medicine (Int J Mol Med) Vol. 41 Issue 4 Pg. 2263-2269 (Apr 2018) ISSN: 1791-244X [Electronic] Greece
PMID29344662 (Publication Type: Journal Article)
Chemical References
  • Interferon Type I
  • NS5 protein, dengue virus
  • STAT Transcription Factors
  • Viral Nonstructural Proteins
  • Janus Kinase 1
  • Janus Kinases
Topics
  • Adolescent
  • Adult
  • Aged
  • Aged, 80 and over
  • Child
  • Dengue (immunology, virology)
  • Dengue Virus (genetics, immunology)
  • Female
  • Genetic Variation
  • Humans
  • Immunity, Innate
  • Interferon Type I (immunology)
  • Janus Kinase 1 (immunology)
  • Janus Kinases (immunology)
  • Male
  • Middle Aged
  • Molecular Docking Simulation
  • Point Mutation
  • STAT Transcription Factors (immunology)
  • Signal Transduction
  • Viral Nonstructural Proteins (genetics, immunology)
  • Young Adult

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: